Valuation: Healius Limited

Market Cap 272M 191M 168M 159M 144M 271M 18.34B 1.9B 735M 9.36B 717M 702M 30.08B P/E 2027 *
-27.4x
P/E 2028 * 62.3x
Enterprise Value 1.15B 809M 712M 673M 611M 1.15B 77.69B 8.06B 3.11B 39.64B 3.04B 2.97B 127B EV / Sales 2027 *
0.82x
EV / Sales 2028 * 0.8x
Free-Float
77.72%
Yield 2027 *
3.32%
Yield 2028 * 5.23%
1 day+6.67%
1 week+6.67%
Current month-5.88%
1 month-8.05%
3 months+2.56%
6 months-25.23%
Current year-55.80%
1 week 0.36
Extreme 0.36
0.42
1 month 0.36
Extreme 0.36
0.48
Current year 0.3
Extreme 0.3
1.05
1 year 0.3
Extreme 0.3
1.07
3 years 0.3
Extreme 0.3
2.36
5 years 0.3
Extreme 0.3
5.54
10 years 0.3
Extreme 0.3
5.54
Manager TitleAgeSince
Chief Executive Officer - 05/03/2024
Director of Finance/CFO - 13/10/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 21/08/2018
Chairman 65 28/11/2023
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
8/27/26 A Expiration

Director

-22,977 0.0032%
8/27/26 A Exercice

Director

22,977 0.0032%
8/18/26 A Expiration

Chief Executive Officer

-305,462 0.0421%
Change 5-day change 1-year change 3-year change Capi.($)
+6.67%+6.67%-46.31%-83.05% 194M
-0.19%+11.10%+152.67%+808.58% 59.47B
-0.02%-3.56%+10.32%+52.30% 25.11B
-0.76%-3.08%-11.12%-36.59% 6.52B
+1.44%-1.18%-5.40%+150.21% 5.57B
-0.52%+2.38%+21.59%+58.70% 3.4B
-2.79%-12.16%-26.69%+2,397.97% 2.64B
-0.21%-0.62%+143.25%+54.20% 2.48B
+14.78%-2.46%+32.84%+41.71% 2.27B
-1.29%+3.57%-0.51%-54.85% 2B
Average +1.71%-0.90%+27.06%+338.92% 10.97B
Weighted average by Cap. +0.13%+4.55%+88.08%+516.34%

Financials

2027 *2028 *
Net sales 1.4B 984M 866M 819M 742M 1.39B 94.47B 9.8B 3.79B 48.21B 3.7B 3.62B 155B 1.44B 1.01B 891M 842M 764M 1.43B 97.23B 10.09B 3.9B 49.61B 3.8B 3.72B 159B
Net income -10.67M -7.49M -6.59M -6.23M -5.65M -10.61M -719M -74.56M -28.8M -367M -28.11M -27.5M -1.18B 1.66M 1.17M 1.02M 969K 879K 1.65M 112M 11.6M 4.48M 57.07M 4.37M 4.28M 183M
Net Debt 881M 618M 544M 514M 466M 876M 59.34B 6.16B 2.38B 30.28B 2.32B 2.27B 97.31B 885M 621M 546M 517M 468M 880M 59.62B 6.18B 2.39B 30.42B 2.33B 2.28B 97.76B
Logo Healius Limited
Healius Limited is a healthcare company. The Company's specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include Abbot, Agilex Biolabs, Dorevitch, Gastrolab, Genomic Diagnostics, IQ Pathology, Kossard Dermatopathology, Laverty Pathology, QML Pathology, TML Pathology, Vetnostics Pathology and Western Diagnostic Pathology (WDP). These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia.
Employees
5,419
Date Price Change Volume
29/09/26 A$0.4000 +6.67% 410,365
28/09/26 A$0.3750 -1.32% 8,678,684
25/09/26 A$0.3800 +5.56% 13,723,863
23/09/26 A$0.3600 -1.37% 11,309,673
22/09/26 A$0.3650 -2.67% 11,252,058
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
0.3750AUD
Average target price
0.5524AUD
Spread / Average Target
+47.31%

Quarterly revenue - Rate of surprise